Controversies in COX-2 selective inhibition.

Simon LS, Smolen JS, Abramson SB, Appel G, Bombardier C, Brater DC, Breedveld FC, Brune K, Burmester GR, Crofford LJ, Dougados M, DuBois RN, Fitzgerald GA, Frishman W, García Rodríguez LA, Hochberg MC, Kalden JR, Laine L, Langman MJ, Prescott SM, van de Putte LB, Whelton A, White WB, Willaims GH
J Rheumatol. 2002 29 (7): 1501-10

PMID: 12136912

MeSH Terms (14)

Anti-Inflammatory Agents, Non-Steroidal Arthritis, Rheumatoid Aspirin Cyclooxygenase Inhibitors Dose-Response Relationship, Drug Drug Interactions Female Gastrointestinal Diseases Humans Male Maximum Tolerated Dose Randomized Controlled Trials as Topic Risk Assessment Sensitivity and Specificity

Connections (1)

This publication is referenced by other Labnodes entities:

Links